# Food and Drug Administration (FDA) Office of Clinical Pharmacology (OCP) – Multi-phase/Multi- site Clinical Studies and Laboratory Support Indefinite Delivery-Indefinite Quantity (IDIQ) Type Contract

Canonical: https://abierto.us/opportunities/75f40124r00064

- Solicitation number: 75F40124R00064
- Notice type: Award notice (first published as combined synopsis and solicitation)
- Status: Awarded to Tranquil Clinical and Research Consulting Services LLC for $50,000,000.00
- Department: Department of Health and Human Services
- Agency: Food and Drug Administration
- Contracting office: FDA Office of Acq Grant SVCS (75F401)
- NAICS: 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Product or service code: AJ12 General Science And Technology R&D Services; General Science And Technology; Applied Research
- Set-aside: Total small business set-aside
- Place of performance: Texas
- County: Harris County (FIPS 48201). https://abierto.us/counties/harris-county-tx-48201
- First posted: July 18, 2024
- Last posted: September 16, 2025
- SAM.gov: https://sam.gov/workspace/contract/opp/b5f18d924b64480295b9816059860a6e/view

## Description

This is a commercial services Food and Drug Administration (FDA) open market single-award Indefinite Delivery-Indefinite Quantity (IDIQ) type contract set aside 100% for small business. The scope of activities FDA may require of the contractor shall include the capability to conduct multiple Phase I clinical trials within a year and at times in parallel, and the provision of a full range of services to support the clinical trials and reporting of the results. The Authorized Task Order (TO) type under this IDIQ contract is Firm-Fixed-Price (FFP).

## Award on USAspending

- Recipient: Tranquil Clinical and Research Consulting Services LLC (UEI FWWJT8QCEDY4)
- Contract: 75F40125D00003
- Obligated: $2,500.00
- Competition: Full and Open Competition After Exclusion of Sources, 3 offers received
- Link: award number 75F40125D00003 equals the contract number; same awarding office 75F401 (high confidence)
- Record: https://www.usaspending.gov/award/CONT_IDV_75F40125D00003_7524/


## Publications

- July 18, 2024: Combined synopsis and solicitation, due September 2, 2024 at 3:00 PM EDT. Notice bc5a92457170469197e4dd89369a8bfd. https://sam.gov/workspace/contract/opp/bc5a92457170469197e4dd89369a8bfd/view
- August 15, 2024: Combined synopsis and solicitation, due September 2, 2024 at 3:00 PM EDT. Notice 7241338dfc21472a8dc4cdf40e091aa7. https://sam.gov/workspace/contract/opp/7241338dfc21472a8dc4cdf40e091aa7/view
- September 16, 2025: Award notice. Notice b5f18d924b64480295b9816059860a6e. https://sam.gov/workspace/contract/opp/b5f18d924b64480295b9816059860a6e/view

## Points of contact

- Craig Wright, craig.wright@fda.hhs.gov, 240-402-3996
- Ian Weiss, Ian.Weiss@fda.hhs.gov, 3017965728

---
Source: SAM.gov Contract Opportunities bulk extract and USAspending.gov award data. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/75f40124r00064.